These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25849181)

  • 1. Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery.
    Akl EA; Kahale LA; Schünemann HJ
    JAMA; 2015 Apr; 313(13):1364-5. PubMed ID: 25849181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Labedi N; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Nov; (11):CD009447. PubMed ID: 22071865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.
    Akl EA; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook DJ; Schünemann HJ
    Arch Intern Med; 2008 Jun; 168(12):1261-9. PubMed ID: 18574082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy.
    Kakkar AK; Haas S; Wolf H; Encke A
    Thromb Haemost; 2005 Oct; 94(4):867-71. PubMed ID: 16270644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis.
    Guo Q; Huang B; Zhao J; Ma Y; Yuan D; Yang Y; Du X
    Ann Surg; 2017 Jun; 265(6):1087-1093. PubMed ID: 27849664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of fatal pulmonary embolism and mortality in surgical patients: a randomized double-blind comparison of LMWH with unfractionated heparin.
    Haas S; Wolf H; Kakkar AK; Fareed J; Encke A
    Thromb Haemost; 2005 Oct; 94(4):814-9. PubMed ID: 16270636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C; Zhai Z; Yang Y; Cheng Z; Ying K; Liang L; Dai H; Huang K; Lu W; Zhang Z; Cheng X; Shen YH; Davidson BL;
    Clin Respir J; 2016 Sep; 10(5):596-605. PubMed ID: 25619125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis in the cancer patient.
    Kakkar AK; Williamson RC
    Haemostasis; 1998; 28 Suppl 3():61-5. PubMed ID: 10069763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative anticoagulation in free microvascular flaps - a comparison of different prophylactic regimes in oncologic reconstructive surgery.
    Tamse HR; Koch M; Mueller SK; Gostian AO; Balk M; Rupp R; Allner M; Iro H; Sievert M
    Eur Rev Med Pharmacol Sci; 2024 May; 28(10):3532-3541. PubMed ID: 38856128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of postoperative thrombosis with low-molecular-weight heparins].
    Jørgensen LN; Wille-Jørgensen PA; Hauch O
    Ugeskr Laeger; 1994 Sep; 156(39):5667-72. PubMed ID: 7985248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review.
    Akl EA; Terrenato I; Barba M; Sperati F; Muti P; Schünemann HJ
    Thromb Haemost; 2008 Dec; 100(6):1176-80. PubMed ID: 19132245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
    Breddin HK
    Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.